Aug 13, 2020
Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference HINGHAM, Mass. , Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference , being held on Monday, August 17, 2020 , Microbot Medical Inc.
Aug 03, 2020
Vascular Interventions Executive Will Contribute Significantly to the Development and Commercialization of LIBERTY Robotic System HINGHAM, Mass. , Aug. 03, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has further strengthened the Company’s capabilities and expertise as Mr.
Apr 01, 2020
Proven Track Record of Numerous M&A and Strategic Collaboration Transactions HINGHAM, Mass. , April 01, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced the appointment of Aileen Stockburger to the Company's Board of Directors, effective April 1, 2020 . Ms.
Mar 03, 2020
HINGHAM, Mass. , March 03, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Microbot Medical Inc.  (NASDAQ: MBOT), please note that in the first paragraph the appointment of Eyal Morag, M.D. has been changed to commencing June 2020 and in the fourth paragraph
Mar 03, 2020
HINGHAM, Mass. , March 03, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), announced the appointment of Eyal Morag , M.D., a leading radiologist, to Chief Medical Officer, effective immediately. In his new role, Dr. Morag will lead the development and execution of the clinical
Jan 08, 2020
HINGHAM, Mass., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has received an official communication from the European Patent Office (EPO) regarding its intention to grant European Patent Application No. 11795301, covering the Company’s Self-Cleaning Shunt (SCS™).
Dec 30, 2019
HINGHAM, Mass. , Dec. 30, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with certain
Dec 30, 2019
HINGHAM, Mass. , Dec. 30, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ) closed its previously announced registered direct offering of 952,383 shares of its common stock at a purchase price of $10.50 per share for total gross proceeds of approximately $10.0 million , before
Dec 27, 2019
HINGHAM, Mass. , Dec. 27, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with certain

Displaying 100 - 108 of 152

Search Investor Relations